IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Talis Biomedical Corp (TLIS)

CUSIP: 87424L207 | NYSE | 30 institutional holders

Quarters

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2024

Synergy Asset Management, LLC14
0.0% of portfolio›$26
StyleTurnoverLocationFiled
Synergy Asset Management, LLC
14$260.0%GrowthHighVancouver, WA2025-01-23